Derek Haight
Pain Medicine · Draper, UTNPI 1588028401
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Nevro Corp. at 30.3% of the total. Among pain medicine clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $178.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$24K
- Globus Medical$22K
- Boston Scientific$17K
- Spinal Simplicity, LLC$5K
- Interventional Pain Technologies Inc.$4K
- Relievant Medsystems, Inc.$1K
- plus $4K from 21 others
What the payments were for
- Consulting fees$20,18826%
- Speaking & faculty fees$29,52538%
- Travel & lodging$15,74720%
- Food & beverage$11,11814%
- Education$1,2502%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 52 | $23,590 |
| Globus Medical | 34 | $22,283 |
| Boston Scientific | 173 | $17,097 |
| Spinal Simplicity, LLC | 20 | $5,397 |
| Interventional Pain Technologies Inc. | 3 | $4,000 |
| Relievant Medsystems, Inc. | 18 | $1,309 |
| Abbott | 14 | $754 |
| Stratus Medical, LLC | 5 | $711 |
| AbbVie(2 entities) | 29 | $548 |
| MML US, Inc. | 11 | $519 |
| Collegium Pharmaceutical, Inc. | 33 | $458 |
| Medtronic(2 entities) | 15 | $422 |
| Biotronik NRO, Inc. | 8 | $294 |
| Merz Pharmaceuticals, LLC | 3 | $63 |
| SPR Therapeutics, Inc | 2 | $50 |
| Vertos Medical, Inc. | 3 | $47 |
| Averitas Pharma Inc. | 2 | $43 |
| Saluda Medical Americas, Inc. | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Hydrocision, Inc. | 1 | $27 |
| Si-bone, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| BD | 1 | $25 |
| Vertex | 1 | $18 |
| Acacia Pharma Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vyrsa V1$31,086
- Senza$17,254
- WaveWriter Alpha Prime 16$8,562
- HA MINUTEMAN G3-R$5,009
- Intracept$3,430
- Superion Indirect Decompression System$2,026
- GENERAL - THERAPIES$1,131
- Nimbus$702
- PROCLAIM$454
- ReActiv8$319
- SPECTRA WAVEWRITER$289
- RESTORE$209
- GENERAL PAIN MANAGEMENT$107
How this compares
$77,827 in reported general payments places this provider in the 90th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 975 | $26,763 |
| BelbucaBuprenorphine Hcl | 22 | $21,787 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 636 | $17,471 |
| Buprenorphine | 25 | $6,642 |
| Gabapentin | 422 | $5,994 |
| Pregabalin | 262 | $4,258 |
| Fentanyl | 22 | $4,122 |
| Duloxetine Hcl | 185 | $2,404 |
| Tramadol Hcl | 202 | $2,291 |
| Celecoxib | 87 | $1,876 |
| Baclofen | 63 | $1,401 |
| Tizanidine Hcl | 115 | $1,047 |
| Tramadol Hcl ErTramadol Hcl | 19 | $982 |
| Lubiprostone | 11 | $794 |
| Cyclobenzaprine Hcl | 68 | $769 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $458 | $21,78722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 61 pain medicine providers in Utah.
Other pain medicine in Draper
- Jeremy JoyalDraper$170K
- Braden WebbDraper$12K
- Maria SchwartzSalt Lake City$813K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
- Jeffrey PenceWest Valley City$13K
- Michael ChenSandy$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.